BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 28513198)

  • 1. Cleaning and infection control of airway clearance devices used by CF patients.
    Manor E; Gur M; Geffen Y; Bentur L
    Chron Respir Dis; 2017 Nov; 14(4):370-376. PubMed ID: 28513198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microbial contamination of nebulizers in the home treatment of cystic fibrosis.
    Blau H; Mussaffi H; Mei Zahav M; Prais D; Livne M; Czitron BM; Cohen HA
    Child Care Health Dev; 2007 Jul; 33(4):491-5. PubMed ID: 17584406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nebulizer cleaning and disinfection practices in families with cystic fibrosis: The relationship between attitudes, practice and microbe colonization.
    Murray TS; O'Rourke TK; Feinn R; Drapeau G; Collins MS
    J Cyst Fibros; 2019 Nov; 18(6):823-828. PubMed ID: 31126899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nebulizers in cystic fibrosis: a source of bacterial contamination in cystic fibrosis patients?
    Brzezinski LX; Riedi CA; Kussek P; Souza HH; Rosário N
    J Bras Pneumol; 2011; 37(3):341-7. PubMed ID: 21755189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microbiological contamination of nebulizers used by cystic fibrosis patients: an underestimated problem.
    Riquena B; Monte LFV; Lopes AJ; Silva-Filho LVRFD; Damaceno N; Aquino EDS; Marostica PJC; Ribeiro JD
    J Bras Pneumol; 2019 May; 45(3):e20170351. PubMed ID: 31166553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequency of contamination of single-patient-use nebulizers over time.
    Weber DJ; Gergen MF; Sickbert-Bennett EE; Short KA; Lanza-Kaduce KE; Rutala WA
    Infect Control Hosp Epidemiol; 2014 Dec; 35(12):1543-6. PubMed ID: 25419779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Device Cleaning and Infection Control in Aerosol Therapy.
    O'Malley CA
    Respir Care; 2015 Jun; 60(6):917-27; discussion 928-30. PubMed ID: 26070583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low level of bacterial contamination of mist tents used in home treatment of cystic fibrosis patients.
    Jakobsson B; Hjelte L; Nyström B
    J Hosp Infect; 2000 Jan; 44(1):37-41. PubMed ID: 10633052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microbiologic contamination study of nebulizers after aerosol therapy in patients with cystic fibrosis.
    Vassal S; Taamma R; Marty N; Sardet A; d'athis P; Brémont F; Dalphin ML; Plésiat P; Rault G; Thubert J; Dominique S; Lemeland JF; Derelle J; Blech MF; Roussey M; Perrin M; Sautegeau A
    Am J Infect Control; 2000 Oct; 28(5):347-51. PubMed ID: 11029133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect that an educational program for cystic fibrosis patients and caregivers has on the contamination of home nebulizers.
    Della Zuana A; Garcia Dde O; Juliani RC; Silva Filho LV
    J Bras Pneumol; 2014; 40(2):119-27. PubMed ID: 24831395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nebulizer use and maintenance by cystic fibrosis patients: a survey study.
    Lester MK; Flume PA; Gray SL; Anderson D; Bowman CM
    Respir Care; 2004 Dec; 49(12):1504-8. PubMed ID: 15571641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of hypochlorite-based disinfection on bacterial contamination of cystic fibrosis patients' home-nebulisers.
    Reychler G; Leonard A; Van Ossel C; Godding V; Gigi J; Simon A; Lebecque P
    J Hosp Infect; 2009 Aug; 72(4):351-7. PubMed ID: 19596489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A day in the life of a nebulizer: surveillance for bacterial growth in nebulizer equipment of children with cystic fibrosis in the hospital setting.
    O'Malley CA; VandenBranden SL; Zheng XT; Polito AM; McColley SA
    Respir Care; 2007 Mar; 52(3):258-62. PubMed ID: 17328823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanical airway clearance using the frequencer electro-acoustical transducer in cystic fibrosis.
    Cantin AM; Bacon M; Berthiaume Y
    Clin Invest Med; 2006 Jun; 29(3):159-65. PubMed ID: 17058435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prevention of nosocomial infection during nebulization and spirometry].
    Dautzenberg B
    Rev Pneumol Clin; 2001 Apr; 57(2):91-8. PubMed ID: 11353915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro evaluation of efficacy of 5 methods of disinfection on mouthpieces and facemasks contaminated by strains of cystic fibrosis patients.
    Reychler G; Aarab K; Van Ossel C; Gigi J; Simon A; Leal T; Lebecque P
    J Cyst Fibros; 2005 Sep; 4(3):183-7. PubMed ID: 16046195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An evaluation of different steam disinfection protocols for cystic fibrosis nebulizers.
    Hohenwarter K; Prammer W; Aichinger W; Reychler G
    J Cyst Fibros; 2016 Jan; 15(1):78-84. PubMed ID: 26233897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low bacterial contamination of nebulizers in home treatment of cystic fibrosis patients.
    Jakobsson BM; Onnered AB; Hjelte L; Nyström B
    J Hosp Infect; 1997 Jul; 36(3):201-7. PubMed ID: 9253701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cleaning of inpatient nebulizer devices in cystic fibrosis patients: the urgent need for universal guidelines.
    Bell J; Moore JE; Millar BC
    J Hosp Infect; 2018 Nov; 100(3):e64-e66. PubMed ID: 30369424
    [No Abstract]   [Full Text] [Related]  

  • 20. Repeated hot water and steam disinfection of Pari LC Plus® nebulizers alter nebulizer output.
    Collins MS; O'Brien M; Schramm CM; Murray TS
    J Cyst Fibros; 2019 Mar; 18(2):233-235. PubMed ID: 30224332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.